Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome

被引：0
作者：
Abdel-Raheem, MM [1 ]
Jamil, MG [1 ]
Potti, A [1 ]
Gross, GG [1 ]
机构：
[1] Univ N Dakota, Sch Med, Dept Internal Med, Fargo, ND 58102 USA
来源：
HAEMATOLOGICA | 2000年 / 85卷 / 11期
关键词：
fludarabine; CLL; nephrotic syndrome;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We present a rare case of leukemia-associated membranous nephropathy presenting as severe nephrotic syndrome. Fludarabine treatment was successful in inducing an effective remission from the chronic lymphocytic leukemia and complete resolution of proteinuria.
引用
收藏
页码：1224 / 1225
页数：2
相关论文
共 50 条
  • [31] Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine
    Wells, T
    Kovacs, MJ
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) : 671 - 674
  • [32] Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia
    Schiavone, EM
    De Simone, M
    Palmieri, S
    Annunziata, M
    Pocali, B
    Copia, C
    D'Amico, MR
    Del Vecchio, L
    Ferrara, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (01) : 23 - 28
  • [33] Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
    Badoux, Xavier C.
    Keating, Michael J.
    Wang, Xuemei
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Faderl, Stefan
    Burger, Jan
    Koller, Charles
    Lerner, Susan
    Kantarjian, Hagop
    Wierda, William G.
    BLOOD, 2011, 118 (08) : 2085 - 2093
  • [34] Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: A phase II study
    Giles, FJ
    O'Brien, SM
    Santini, V
    Gandhi, V
    Plunkett, W
    Seymour, JF
    Robertson, LE
    Kantarjian, HM
    Keating, MJ
    LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 57 - 65
  • [35] Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy
    Dwyer, J. P.
    Yates, K. M.
    Sumner, E. L.
    Stone, W. J.
    Wang, Y.
    Koury, M. J.
    Fogo, A. B.
    Zent, R.
    CLINICAL NEPHROLOGY, 2007, 67 (03) : 176 - 181
  • [36] Occurrence of associated tumours in chronic lymphocytic leukemia
    Laszlo, Szerafin
    Janos, Jako
    Lorant, Varju
    ORVOSI HETILAP, 2016, 157 (44) : 1752 - 1756
  • [37] Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    MA Weiss
    M Glenn
    P Maslak
    Z Rahman
    A Noy
    A Zelenetz
    DA Scheinberg
    DW Golde
    Leukemia, 2000, 14 : 1577 - 1582
  • [38] Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    Weiss, MA
    Glenn, M
    Maslak, P
    Rahman, Z
    Noy, A
    Zelenetz, A
    Scheinberg, DA
    Golde, DW
    LEUKEMIA, 2000, 14 (09) : 1577 - 1582
  • [39] Commonality of rituximab pharmacokinetic disposition in nephrotic syndrome and autoimmune cytopenias in chronic lymphocytic leukemia patients
    Srinivas, Nuggehally R.
    PEDIATRIC NEPHROLOGY, 2016, 31 (02) : 335 - 336
  • [40] Commonality of rituximab pharmacokinetic disposition in nephrotic syndrome and autoimmune cytopenias in chronic lymphocytic leukemia patients
    Nuggehally R. Srinivas
    Pediatric Nephrology, 2016, 31 : 335 - 336
12345